Our previous bioinformatics analysis of several public gene expression profiles showed that STX2 upregulation was correlated with a poor prognosis for CRC patients and could increase the activity of the NF-κB signaling pathway17. This evidence concerns the gene NFKB1 and colorectal carcinoma.